S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

CTCX Carmell Corporation

0.57

0.07767 (15.78%)

Last Updated: 14:15:55

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Exhibit 24

Carmell (NASDAQ:CTCX)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Carmell Charts.

Carmell (NASDAQ:CTCX)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Carmell Charts.

Carmell Therapeutics Corporation News

Carmell Announces Closing of Previously Announced PIPE Investment from Existing and New Investors to Support Commercial Build-out
Friday 3 January 2025 (1 week ago) • GlobeNewswire Inc.

Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products
Thursday 2 January 2025 (2 weeks ago) • GlobeNewswire Inc.

Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products
Thursday 2 January 2025 (2 weeks ago) • GlobeNewswire Inc.

This Biotech Stole The Show Following Securities Purchase Agreement Announcement
Tuesday 24 December 2024 (3 weeks ago) • AllPennyStocks.com

Carmell Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out
Tuesday 24 December 2024 (3 weeks ago) • GlobeNewswire Inc.

Carmell Corporation Appoints New CEO Following Addition to the Russell Microcap Index
Monday 29 July 2024 (6 months ago) • GlobeNewswire Inc.

Carmell Announces Successful Closing of $3.0 Million Private Placement
Thursday 11 April 2024 (9 months ago) • GlobeNewswire Inc.

Carmell Announces $3.0 Million Private Placement
Thursday 4 April 2024 (9 months ago) • GlobeNewswire Inc.

Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction
Wednesday 27 March 2024 (10 months ago) • GlobeNewswire Inc.

Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary
Wednesday 20 March 2024 (10 months ago) • GlobeNewswire Inc.

Carmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics Field
Monday 18 March 2024 (10 months ago) • GlobeNewswire Inc.

Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024
Monday 26 February 2024 (11 months ago) • GlobeNewswire Inc.

More Carmell Therapeutics Corporation News Articles

Investec Bnk 24

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions